In PCa, the common imaging modalities are MRI (including T1, T2 weighted and diffusion-weighted) transrectal ultrasound, conventional CT, conebeam CT and molecular imaging, often in the form of PET/CT, with tracers such as radiolabeled Prostate Specific Membrane Antigen (PSMA) [17] and fluorine labeled 18F-choline [18]. Here, FOLH1 is linked to posterior cortical atrophy.